- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||timolumab|
|Search PubMed titles||timolumab|
|Search PubMed titles/abstracts||timolumab|
|Tmolumab is a fully human anti-AOC3 (amine oxidase copper containing 3, VAP1) monoclonal antibody being investigated for its immunomodulatory action.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent US7897149, in particular with the recombinant fully human antibody BTT-1023 named therein .